Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia

Autor: J. Nauta, H.M. Pinedo, Joke W. Baars, C.E. Hack, A.J.M. Eerenberg-Belmer, D. Roem, John Wagstaff, J. de Boer

Publikováno v: Baars, J W, de Boer, J P, Wagstaff, J, Roem, D, Eerenberg-Belmer, A J M, Nauta, J, Pinedo, H M & Hack, C E 1992, ' Interleukin-2 induces activation of coagulation and fibronolysis: resemblance to the changes seen during experimental endotoxaemia ', British Journal of Haematology, vol. 82, pp. 295-301 .
British Journal of Haematology, 82, 295-301. Wiley-Blackwell

The administration of Interleukin-2 (IL-2) causes the release or generation of other cytokines such as tumour necrosis factor (TNF) which, by disturbing the anticoagulant properties of the endothelium, may induce a procoagulant state in patients rece

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8fc7a2ee505b0729b031209012c9ff3
https://doi.org/10.1111/j.1365-2141.1992.tb06421.x

Shock I

Autor: I. Glovannini, C. Chiarla, G. Boldrini, M. Castagneto, S. C. Beards, T. Watt, J. D. Edwards, P. Nightingale, O. Boyd, J. Mackay, G. Lamb, R. M. Grounds, E. D. Bennett, P. Munerato, A. Fracasso, D. Fantin, R. Bortolussi, F. Giaimo, C. Santantonio, M. Jienenez Lendinez, J. Lopez, V. Cerdeno, A. Monjas, M. A. Arce, A. G. de Lorenzo, R. de la Casa, L. Lind, J. Mälstam, G. Skoog, D. Mathìeu, R. Nevìere, F. Herengt, M. Fleyfel, F. Wattel, A. Meier-Hellmann, L. Hannemann, M. Specht, W. Schaffartzik, W. Heiss-Dunlop, H. Hassel, K. Reinhart, P. G. Silance, J. L. Vincent, P. G. Berlot, G. Berlot, H. Zhang, K. H. Smolle, R. J. Kahn, J. A. Sanchez-Izquierdo Riera, E. Alted López, S. Bermejo Aznarez, E. Renes, M. J. Jiménez Martín, A. Martínez Dela Gándara, J. Prados, P. Arribas López, J. Gutierrez Rodriguez, J. Prados Varela, A. Léon, P. Raclot, J. Cousson, C. Biotteau, J. L. Suinat, J. Rendoing, J. G. van der Hoeven, H. Waanders, E. A. Compier, A. E. Meinders, K. H. Lindner, W. Schümann, E. G. Pfenninger, F. W. Ahnefeld, H. Strohmenger, A. Brinkmann, M. Georgieff, G. Verde, F. Bobbio Pallavicini, F. Caramella, F. Cassini, G. Bichisao, C. Ferguson, F. Withey, J. Coakley, P. Crane, M. Honovar, C. J. Hinds, I. von Planta, O. Wagner, R. Ritz, M. von Planta, A. B. J. Groeneveld, L. G. Thijs, J. P. de Boer, J. J. Abbink, A. A. Creasey, A. Chang, D. Roem, A. J. M. Eerenberg, C. E. Hack, F. B. Taylor, D. Annane, J. C. Raphaël, Ph. Gajdos, G. Bernardin, D. Milhaud, C. Pradier, M. Matlei, A. Donati, E. Adrario, M. Valente, G. Orsetti, G. Sambo, L. Cola, C. Giovannini, P. Pietropaoli, D. D. Tran, M. A. Cuesta, A. J. Schneider, R. I. C. Wesdorp, V. D’Orio, C. Martinez, G. Saad, P. Mendes, R. Marcelle, T. Boulain, A. Legras, D. Perrotin, G. Giniès, S. Geroulanos, M. Cakmakci, J. Schilling, Karl-Hermann Staubach, G. Audibert, M. Donner, J. C. Lefèvre, J. F. Stoltz, M. C. Laxenaire, R. Russo, G. Veschi, E. Dellino, M. Solca, R. Aveni, A. Colombo, G. Iapichino, B. Coronet, A. Mercatello, M. Bret, N. Lefrançois, I. M. Dubernard, J. F. Moskovtchenko

Publikováno v: Intensive Care Medicine. 18:S126-S135

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b2024c4141e77ccd21c12beff23c11a
https://doi.org/10.1007/bf03216352

Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor

Autor: W A, Wuillemin, M, Minnema, J C, Meijers, D, Roem, A J, Eerenberg, J H, Nuijens, H, ten Cate, C E, Hack

Publikováno v: Blood. 85(6)

From experiments with purified proteins, it has been concluded that factor XIa (FXIa) is inhibited in plasma mainly by alpha 1-antitrypsin (a1AT), followed by antithrombin III (ATIII), C1-inhibitor (C1Inh), and alpha 2-antiplasmin (a2AP). However, th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cb7a6ce420c2051c9c756cea68d14c76
https://pubmed.ncbi.nlm.nih.gov/7534133

Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo

Autor: M, Levi, D, Roem, A M, Kamp, J P, de Boer, C E, Hack, J W, ten Cate

Publikováno v: Thrombosis and haemostasis. 69(2)

It has been shown that the most important inhibitor of plasmin is alpha 2-antiplasmin, however, other protease inhibitors are able to inhibit this proteolytic enzyme as well. The contribution of the various protease inhibitors to the inhibition of pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::95aaab6e880c4b5ba36c8c067284f280
https://pubmed.ncbi.nlm.nih.gov/7681223

Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay

Autor: M, Levi, J P, de Boer, D, Roem, J W, ten Cate, C E, Hack

Publikováno v: Thrombosis and haemostasis. 67(1)

Infusion of desamino-d-arginine vasopressin (DDAVP) results in an increase in plasma plasminogen activator activity. Whether this increase results in the generation of plasmin in vivo has never been established. A novel sensitive radioimmunoassay (RI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::810fe7a431c678552339d9f2065069b5
https://pubmed.ncbi.nlm.nih.gov/1377412